J. Elborn

Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection.

J. Elborn, P. Flume, D. VanDevanter, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Testing Two Different Doses of Tiotropium Respimat® in Cystic Fibrosis: Phase 2 Randomized Trial Results

Qiqi Deng, J. Bradley, J. Bradley, 2014, PloS one.

Bronchiectasis in secondary care: a comprehensive profile of a neglected disease.

J. Elborn, M. Kelly, S. Murphy, 2003, European journal of internal medicine.

Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis

S. Birring, M. Tsagris, K. Fragkos, 2021, European Respiratory Journal.

Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis.

J. Elborn, A. Hill, S. Aliberti, 2016, Respiratory medicine.

Airway Clearance in Bronchiectasis: A Randomized Crossover Trial of Active Cycle of Breathing Techniques versus Acapella®

I. Bradbury, J. Bradley, J. Elborn, 2005, Respiration.

Lung Clearance Index in Adults and Children With Cystic Fibrosis.

I. Bradbury, J. Bradley, M. Tunney, 2016, Chest.

Temocillin in cystic fibrosis: a retrospective pilot study.

I. Bradbury, L. Kent, G. Döring, 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Expert patient self-management program versus usual care in bronchiectasis: a randomized controlled trial.

B. O'Neill, K. Lavery, J. Elborn, 2011, Archives of physical medicine and rehabilitation.